Carbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study

dc.authorid0000-0003-0398-9216
dc.authorid0000-0001-8217-1767
dc.authorid0000-0002-3884-9347
dc.authorid0000-0001-6323-1410
dc.authorid0000-0003-3990-7956
dc.authorid0000-0001-5684-1667
dc.authorid0000-0002-2860-1794
dc.contributor.authorErgen, Pınar
dc.contributor.authorKocoglu, M. Esra
dc.contributor.authorNural, Muge
dc.contributor.authorKuskucu, Mert Ahmet
dc.contributor.authorAydin, Ozlem
dc.contributor.authorInal, Ferda Y.
dc.contributor.authorOzturk, Hande
dc.date.accessioned2025-05-10T19:45:18Z
dc.date.issued2022
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractWe analysed a carbapenem-resistant Klebsiella pneumoniae (CRKP) outbreak in the coronavirus disease (COVID) ICU. We retrospectively collected data from ICU records. We identified 25 cases between 12 November 2020 and 19 December 2020, and compared them to 42 controls present in the ICU during the same period. The presence of a femoral haemodialysis catheter was strongly associated with invasive CRKP infections (cases, 9 [36%]; controls, 0 [0%]; odds ratio [OR] 95% confidence intervals [CIs], 21 (5; 89)). We found a significant association between old age and CRKP infection with adverse outcomes. Sequence analysis revealed three distinct carbapenemase genes: bla(NDM-1), bla(OXA-48) and bla(KPC-2). We launched rectal swab sampling upon admission to the ICU, cohorted colonized patients and cases and conducted an intensive training programme for newly employed staff. This study revealed that the emergence and dissemination of CRKP in COVID ICUs were associated with increased adverse outcomes. The presence of a femoral haemodialysis catheter was a significant risk factor for CRKP infections.
dc.identifier.doi10.1080/1120009X.2022.2064698
dc.identifier.endpage523
dc.identifier.issn1120-009X
dc.identifier.issn1973-9478
dc.identifier.issue8
dc.identifier.pmid35470780
dc.identifier.scopusqualityQ3
dc.identifier.startpage517
dc.identifier.urihttps://doi.org/10.1080/1120009X.2022.2064698
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11201
dc.identifier.volume34
dc.identifier.wosWOS:000787700600001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Chemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectKlebsiella pneumoniae
dc.subjectCarbapenemases
dc.subjectmicrobial drug resistance
dc.subjectCOVID-1
dc.subjectretrospective studies
dc.subjectrisk factors
dc.titleCarbapenem-resistant Klebsiella pneumoniae outbreak in a COVID-19 intensive care unit; a case-control study
dc.typeArticle

Dosyalar